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1398Objective: Sternal dehiscence after open surgery is a major cause of morbidity and mortality, and chronic ob-
structive pulmonary disease is a significant risk factor. Therefore, we aimed to determine whether moderate and
severe chronic obstructive pulmonary disease had an effect on the development of sternal dehiscence and
whether the use of the Robicsek technique for sternal closure along with sternal support vest postoperatively
would reduce the incidence of sternal dehiscence in patients with moderate/severe chronic obstructive pulmo-
nary disease undergoing cardiac surgery.
Methods: Two studies were performed. In study 1, 842 patients undergoing cardiac surgery and figure-of-8 wire
closure were retrospectively evaluated in 2 groups: group 1a (328 patients with chronic obstructive pulmonary
disease) and group 1b (514 patients without chronic obstructive pulmonary disease). In study 2, 221 patients
with moderate and severe COPD who were scheduled for open surgery were prospectively enrolled. The Robic-
sek techniquewas used for sternal closure. The postoperative thorax support vest was used in 100 patients (group
2a), and no additional procedure was applied in 121 patients (group 2b).
Results: In study 1, the dehiscence rate was significantly higher in group 1a (7.9%) than in group 1b (1.2%;
P<.001), and mortality rates in patients with dehiscence were 53.8% and 33.3%, respectively. In study 2,
the dehiscence rate was significantly lower in group 2a (1%) than in group 2b (11.5%; P ¼ .002). None of
the patients with dehiscence in group 2a died, and 35.7% of patients died in group 2b.
Conclusions: The Robicsek technique for sternal closure and the use of a thorax support vest postoperatively are
highly effective in preventing sternal dehiscence after cardiac surgery in patients with moderate and severe
chronic obstructive pulmonary disease. (J Thorac Cardiovasc Surg 2011;141:1398-402)Sternal dehiscence after median sternotomy is a serious
complication and may lead to prolonged hospitalization, in-
creased cost of care, and significant mortality.1-4 Chronic
obstructive pulmonary disease (COPD) is one of the
major risk factors for sternal dehiscence in patients
undergoing cardiac surgery.5-7 The benefits of reinforced
sternal closure techniques are controversial. Previous
studies have shown that reinforced closure of the sternum
may decrease sternal dehiscence rate in high-risk pa-
tients.8-10 In addition, the use of a thorax support vest
after the operation has been shown to reduce sternal
wound complications.11 We evaluated the influence of
COPD on the development of sternal dehiscence in patients
undergoing cardiac surgery in the first study. In the second
study, we evaluated whether the use of a postoperative tho-e Thoracic Surgery Division, Thoracic Department,a Thoracic Surgery Divi-
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The Journal of Thoracic and Cardiovascular Surrax support vest along with the Robicsek sternal closure
technique would reduce the rate of sternal dehiscence after
cardiac surgery in patients with moderate and severe COPD.
MATERIALS AND METHODS
Selection and Description of Participants
Two studies were performed. In the first study, we retrospectively eval-
uated the incidence and mortality of sternal dehiscence after cardiac sur-
gery in patients with and without COPD. In the second study, we
prospectively enrolled patients with COPD who were scheduled for open
surgery. The studies were performed in the Medicana Hospitals Group in
Istanbul, Turkey, and were approved by the Clinical Research Ethics Com-
mittee of the hospitals. Written informed consent was obtained from all pa-
tients enrolled in the prospective study.
Patients with chronic infectious diseases (eg, brucellosis and hepati-
tis), emergency sternotomy, repeat sternotomy, prior radio/chemotherapy,
off-pump surgery, or previous thoracic trauma were excluded in both
studies.
COPD was classified according to American Thoracic Society guide-
lines.12 Moderate COPD was defined as less than 50% forced expiratory
volume in 1 second (FEV1) less than 80% of the predicted value, and se-
vere COPD was defined as less than 30% FEV1 less than 50% of the pre-
dicted value. Diagnosis of sternal dehiscence was made on the basis of
clinical criteria and lateral and posterior-anterior chest radiographs, and
multislice computed tomography if required. Isolated sternal dehiscence
was defined as ‘‘partial or complete dehiscence of skin, soft tissue, and ster-
num without infection (mechanical, pain, and clicking).’’ The descriptions
proposed by El Oakley and Wright13 were used: superficial sternal wound
infection as ‘‘a redness, swelling, bogginess or frank discharge (bloodgery c June 2011
Abbreviations and Acronyms
COPD ¼ chronic obstructive pulmonary disease
FEV1 ¼ forced expiratory volume in 1 second
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Sstained or purulent from skin and subcutaneous tissue)’’ and deep sternal
infection as ‘‘complete separation of the sternum, mediastinitis, and frank
pus discharge from an open wound.’’
In the interpretation of chest radiographs, sternal dehiscence was de-
fined as a mid-sternal stripe of lucency, sternal wire displacement (2 cm
of displacement seen in 2 wires), and sternal wire breaks.14 In computed
tomography evaluations, mediastinitis was defined as small air bubbles or
an air-fluid level in the mediastinum.
In study 1, 842 patients with and without COPD, who had undergone
elective cardiac surgery via midline sternotomy between July 2004 and
September 2007, were retrospectively evaluated. The peristernal figure-
of-8 wire closure technique had been used in sternal closure in all patients.
The patients were analyzed in 2 groups: group 1a (patients with COPD) and
group 1b (patients without COPD). Furthermore, to evaluate the relation
between respiratory functions and sternal dehiscence in patients with
COPD, group 1a was divided into 5 subgroups according to predicted
FEV1 values.
In study 2, 221 patients with moderate and severe COPD undergoing
open surgery between December 2007 and September 2009 were prospec-
tively analyzed. The study was planned for 244 patients, 122 patients for
each group. Patients were randomly assigned to 2 groups 1 to 2 weeks be-
fore surgery: vest and non-vest. A computer-generated randomization list
was used, and individual allocations were placed in sealed envelopes. An
external investigator blinded to the allocation sequence picked consecutive
allocation envelops for consecutive participants.
The Robicsek closure techniquewas used in the sternal closure of all pa-
tients. The patients were randomly allocated into 2 groups; sternal support
vests were used postoperatively in group 2a, and no additional procedure
was performed in group 2b. The patients were followed up for 6 months.
All patients evaluated in the 2 studies received preoperative physiother-
apy for 7 days. Other risk factors associated with sternal dehiscence, in-
cluding diabetes mellitus, obesity (body mass index > 30 kg/m2),
osteoporosis, reexploration for bleeding, and use of bilateral internal tho-
racic artery grafts, were also analyzed.
Statistics
Continuous and normally distributed data are expressed as mean stan-
dard deviation. Categoric data are shown as percentages. Univariate anal-
ysis of categoric data was carried out using the Pearson chi-square and
Fisher exact tests for categoric variables, and the unpaired t test for contin-
uous variables. In the prospective study (study 2), analysis was performed
in patients who completed the trial. Sternal dehiscence rate was calculated
according to COPD severity.RESULTS
There were 328 patients with COPD (group 1a) and 514
patients without COPD (group 1b) in study 1. Patient char-
acteristics, comorbidities, procedure-related variables, and
duration of hospitalization are shown in Table 1. No signif-
icant difference was found between the 2 groups with regard
to age, gender, presence of risk factors (eg, osteoporosis, pe-
ripheral arterial disease, diabetes, and chronic renal failure),
and procedure-related variables (P>.05).The Journal of Thoracic and CarIn group 1a (COPD group) and group 1b (non-COPD
group), 26 of 328 patients (7.9%) and 6 of 514 patients
(1.1%) had a sternal dehiscence diagnosis. The dehiscence
rate was significantly higher in the COPD group than in the
non-COPD group (P<.001). Although the rates of isolated
dehiscence and superficial wound infections were similar
between the 2 groups, the rate of deep sternal wound infec-
tions was higher in the COPD group than in the non-COPD
group (P< .001). Furthermore, COPD severity also had
a significant effect (P¼ .002) on the development of sternal
dehiscence. In patients with COPD, sternal dehiscence inci-
dence was 3.5% (3/85) among patients with an FEV1 value
of 60% to 70% and 45.4% (10/22) among patients with an
FEV1 value of 30% to 40% (Figure 1).
Debridement and Robicsek closure were performed in all
26 patients with dehiscence in group 1a. Of these 26 patients,
12 (46.2%) improved and 14 (53.8%) died of mediastinitis
and sepsis despite all efforts of rewiring and debridement.
In group 1b (non-COPD group), 6 (1.1%) of 514 patients
with a sternal dehiscence diagnosis were treated using the
same method; 2 of these 6 patients (33.3%) died of respira-
tory insufficiency and sepsis, and 4 of 6 patients (66.6%)
recovered after the reoperation.
The mortality rate of the COPD group with sternal dehis-
cence (53.8%; 14/26) was significantly higher than the
mortality rate of the non-COPD group with sternal dehis-
cence (33.3%, 2/6; P<.001).
Study 2
The study was planned for 244 patients, 122 patients for
each group. However, only 221 patients were eligible for
analysis, because 23 patients withdrew their consents in dif-
ferent phases of the study (1 from the non-vest arm and
22 from the vest arm). Twenty-one who withdrew their
consents in the vest arm were obese female patients, and 1
was an elderly male patient who found it difficult to wear
the vest. The patient who withdrew his consent in the non-
vest arm wanted to wear a vest for his chest pain. The power
of the studywas calculated backward, and it was determined
that group sample sizes of 100 and 121 were adequate to
achieve 86% power to detect a difference of 11% in deep
sternal wound complications between the 2 groups.
No significant difference with regard to age, gender,
presence of risk factors (eg, osteoporosis, peripheral arterial
disease, diabetes, and chronic renal failure), and procedure-
related variableswas observedbetween the 2 groups evaluated
in the second study (P>.05) (Table 1). The use of a support
vest was associated with a significantly shorter duration of
hospitalization (13.7 6.7 days vs 17.8 15.4 days,P¼ .03).
With the experimental event ratio as 0/100 ¼ 0 and the
control event ratio as 8/121, the decrease in the relative
risk was calculated as 0.066. Therefore, we estimated that
15 patients would need to be treated to prevent 1 sternal
wound complication.diovascular Surgery c Volume 141, Number 6 1399
TABLE 1. Clinical and demographic data of the patients included in the studies
Study 1 Study 2
Group 1a
COPD
n ¼ 328
Group 1b
Non-COPD
n ¼ 514 P
Group 2a
Vest
n ¼ 100
Group 2b
Non-vest
n ¼ 121 P
M/F (n/n) 209/119 330/214 .60 66/34 82/39 .61
Age (y) 68.22  8.31 67.60  8.52 .70 66.34  7.13 68.44  9.22 .78
EF<35 (%) 26 (8) 51 (10) .68 5 (5) 8 (7) .73
COPD (%)
Moderate 266 (81.1) 63 (63) 61 (50.4) .85
Severe 62 (18.9) 37 (37) 39 (49.6) .87
BMI>30 kg/m2 (%) 102 (31) 149 (29) .70 28 (28) 31 (26) .81
NYHA class 3 and 4 (%) 131 (40) 221 (43) .71 39 (39) 46 (38) .72
DM (%) 121 (37) 216 (42) .63 44 (44) 57 (47) .60
CRF (%) 23 (7) 36 (7) .83 8 (8) 12 (10) .85
PAD (%) 108 (33) 190 (37) .75 27 (27) 28 (23) .70
Steroid use (%) 26 (8) 31 (6) .23 9 (9) 10 (8) .12
Sternal Osteoporosis (%) – – – 34 (34) 48 (40) .60
CABG (%) 233 (68) 344 (67) 65 (65) 80 (66)
CABG plus valve (%) 20 (6) 36 (7) 7 (7) 6 (5)
Valve (%) 59 (18) 98 (19) 16 (16) 18 (15)
Aortic aneurysm (%) 10 (3) 21 (4) 5 (5) 7 (6)
Others (%) 16 (5) 21 (4) 7 (7) 8 (7)
ECC (min) 126  38 123  44 .75 117  61 125  64 .80
AXC (min) 75  25 78  33 .60 71  27 73  31 .65
IABP (%) 10 (3) 10 (2) .70 4 (4) 4 (3) .71
Ventilation support (h) 24  33 24  37 .65 24  38 24  41 .75
Reexploration for bleeding (%) 23 (7) 41 (8) .50 5 (5) 8 (7) .50
Postoperative delirium (%) 98 (30) 144 (28) .80 25 (25) 40 (33) .76
Hospitalization (d)
ICU stay 3.5  4.1 3.8  4.3 .72 3.2  3.6 2.9  3.2 .76
Hospital stay 15.4  7.4 17.1  9.4 .80 13.7  6.7 17.8  15.4 .03
COPD, Chronic obstructive pulmonary disease; EF, ejection fraction; BMI, body mass index; NYHA, New York Heart Association; DM, diabetes mellitus; CRF, chronic renal
failure; PAD, peripheral arterial disease; CABG, coronary artery bypass graft; ECC, extracorporeal circulation time; AXC, aortic crossclamp time; IABP, intraaortic balloon pump;
ICU, intensive care unit.
FIGURE 1. Incidence of sternal dehiscence in patients with moderate and
severe COPD according to FEV1 subgroups. FEV1, Forced expiratory vol-
ume in 1 second.
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curred in only 1 (1%), a 67-year-old man with severe
COPD. Although the patient had isolated (noninfectious)
sternal dehiscence after discharge at the postoperative
17th day, he did not want reoperation and preferred to use
the sternal support vest. He showed no clinical deteriora-
tion; he was still sterile and clinically stable at the end of
the follow-up period (Figure 2). Of the 121 patients in group
2b (patients with COPD without vest), isolated dehiscence
developed in 3 (2.5%), superficial wound infection devel-
oped in 3 (2.5%), and deep sternal wound infection devel-
oped in 8 (6.6%). We used titanium bars in 3 patients. After
the reoperation, 9 of 14 patients (64.3%) recovered, but 5 of
14 patients (35.7%) died of mediastinitis and sepsis, al-
though the patients underwent reoperation with bilateral
pectoralis major muscle flaps. Although there were no
deaths among the patients whowore thorax support vests af-
ter the operation, 35.7% of the patients without a vest died.
The rates of dehiscence and infection are summarized in
Table 2. Patients treated with a thorax support vest had1400 The Journal of Thoracic and Cardiovascular Surgery c June 2011
FIGURE 2. Multislice tomography showing the sternal dehiscence after
Robicsek closure in a patient from study 2. The peristernal wires became
loose in every level; therefore, they lose their efficiency on the parallel
reinforcement sutures bringing the sternum together.
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11.5%; P ¼ .002) and deep sternal wound infections (0%
vs 6.6%, P¼ .009); however, the rates of superficial wound
infections (0% vs 2.5%, P ¼ .253) and isolated sternal de-
hiscence (1% vs 2.5%, P¼ .628) were similar between the
2 groups.DISCUSSION
Sternal dehiscence after cardiac surgery causes signifi-
cant morbidity and mortality. COPD is one of the most im-
portant risk factors for sternal dehiscence, and its
prevalence is increasingly frequent in patients undergoing
cardiac surgery. COPD incidence was actually 28.4%
among patients who were undergoing open surgery in ourTABLE 2. Incidence and types of dehiscence in both studies
Study 1 (n ¼ 842) Study 2 (n ¼ 221)
Group 1a
COPD
n ¼ 328
Group 1b
Non-COPD
n ¼ 514 P
Group 2a
Vest
n ¼ 100
Group 2b
Non-vest
n ¼ 121 P
ISD 6 (1.8) 3 (6) .098 1 (1) 3 (2.5) .628
SSWI 4 (1.2) 1 (0.2) .079 – 3 (2.5) .253
DSWI 16 (4.9) 2 (0.4) <.001 – 8 (6.6) .009
Total 26 (7.9) 6 (1.2) <.001 1 (1) 14 (11.5) .002
COPD, Chronic obstructive pulmonary disease; ISD, isolated sternal dehiscence;
SSWI, superficial sternal wound infection; DSWI, deep sternal wound infection.
Data are presented as n (%) for each group.
The Journal of Thoracic and Carhospital during the time period of the first study. Because
668 patients were not included in the study according to ex-
clusion criteria, stated as urgent surgery, redo surgery, off-
pump surgery, and infectious diseases, such as hepatitis
and sternal pathologies. Gunen and colleagues15 reported
that the prevalence of COPD was 18.1% in smokers aged
more than 40 years in a large region in Turkey. Kandemir
and colleagues16 determined that COPD frequency was
39.2% in patients undergoing coronary bypass surgery in
a region where the majority of the inhabitants were mine
workers. Furthermore, we know that most of the patients
undergoing coronary bypass surgery have a 30 pack-year
smoking history in Turkey, and the rate reaches 80%.
This is one of the most important reasons why COPD and
coronary artery diseases are prevalent in Turkey.
A prospective study evaluating the rate of sternal dehis-
cence after cardiac surgery, particularly in patients withmod-
erate and severe COPD, has not yet been presented.However,
COPDhas been shown to be associatedwith highermorbidity
and mortality rates after coronary artery bypass grafting,5-7
and some studies have established a greater risk for
experiencing sternal wound complications.1,10 Similarly, in
the first study, the dehiscence rate was significantly higher
in patients with COPD, especially in those with an FEV1
value of 30% to 40% of the predicted value.
Sternal instability usually occurs in the first few days or
weeks after median sternotomy and may lead to dehiscence
because of the fracture of the sternal bone or the sternal
wires.1 Because of coughing and respiratory movements
of the chest wall, the steel wires loosen; the sternal halves
separate and cut the sternum into segments.17 Therefore, ad-
ditional measures, such as sternal vests, are needed in the
early postoperative period. The Posthorax (Epple Inc,
Vienna, Austria), a newly designed thorax support vest,
was produced as an additional tool in postoperative care af-
ter median sternotomy.11
It is important to improve the coughwith respiratory phys-
iotherapy and bronchodilators before the surgery. Previous
studies have shown that preoperative physiotherapy de-
creases pulmonary complications after coronary artery by-
pass grafting, and its continuation prevents pulmonary
complications in the postoperative period.18,19 Furthermore,
discontinuation of smoking and vigorous pulmonary toilet
before surgery are essential in preventing postoperative
pulmonary complications in patients with COPD. All
patients evaluated in both studies received respiratory
physiotherapy, including incentive spirometry, deep brea-
thing exercises, expectoration, and bronchodilator therapy
for 1 or 2 weeks before surgery and in the postoperative
period.
There is no consensus among surgeons on the optimal
method for sternal closure, particularly in high-risk pa-
tients. However, sternal closure reinforcement techniques
versus conventional sternal closure technique have beendiovascular Surgery c Volume 141, Number 6 1401
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the incidence of sternal dehiscence.8-10 Therefore, the
Robicsek method still remains the gold standard for high-
risk patients according to the literature. In study two, 3 of
9 patients who underwent reoperation and recovered after
the development of sternal dehiscence had multiple frac-
tures in the sternum. We treated these patients with titanium
bars. Rigid fixation methods are particularly used for this
purpose in the reported literature.20
We applied the Robicsek closure method to all patients in
the prospective study and found that Posthorax use after Ro-
bicsek closure significantly decreased the rate of sternal de-
hiscence and mortality. Gorlitzer and colleagues11 were the
first to describe and demonstrate the reduction in sternal
wound complications after cardiac surgery with Posthorax
use. However, comparative rates of sternal wound compli-
cations and the efficiency of the vest in high-risk groups
have not been reported. It is important that the Posthorax
vest ensures anteroposterior stabilization while holding
the sternum halves together without creating any unwanted
pressure. The Posthorax vest also serves as a shock absorber
for the sternum, by the 2 cushions placed longitudinally to
the right and left, which is especially helpful when the pa-
tient coughs or breathes deeply. Because the Posthorax is
an easy to use device and has adjustable fittings, family
members and nursing staff easily learn the application of
the device. However, the device is still expensive, and it
does not seem practical to adjust and use the device in obese
female patients.
The primary aim of our study was to evaluate the effects
of moderate to severe COPD on the sternal dehiscence rate
and whether application of vests decreases the rate of ster-
nal dehiscence. Therefore, we did not evaluate all the risk
factors affecting sternal complications. This may be re-
garded as a limitation of the present study.CONCLUSIONS
Moderate to severe COPD is a significant risk factor for
sternal dehiscence after cardiac surgery. The use of a thorax
support vest after the Robicsek closure method after median
sternotomy in patients with moderate and severe COPD un-
dergoing cardiac surgery seems to effectively reduce sternal
wound complications and mortality. However, because the
use of thorax support vests is not suitable in obese female
patients, different treatment alternatives must be considered1402 The Journal of Thoracic and Cardiovascular Surto decrease sternal wound complications, particularly in
those with big breasts.
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